Literature DB >> 24282727

Reproducibility of myocardial perfusion reserve - variations in measurements from post processing using commercially available software.

Pavel Goykhman1, Puja K Mehta, Megha Agarwal, Chrisandra Shufelt, Piotr J Slomka, Yuching Yang, Yuan Xu, Leslee J Shaw, Daniel S Berman, Noel Bairey Merz, Louise E J Thomson.   

Abstract

PURPOSE: Adenosine stress first pass cardiac magnetic resonance imaging (CMRI) is a rapidly evolving tool in the diagnosis of ischemic heart disease (IHD). The rest and stress first pass myocardial perfusion data may be interpreted using commercially available software for calculation of time intensity curves in order to generate a numeric value of the segmental or whole heart myocardial perfusion reserve index (MPRI). The objective of this study was to determine the inter- and intra-observer reliability of the data generated by standard commercially available software.
METHODS: Data from 20 adenosine stress CMRI (1.5 T) studies were analyzed using commercially available CAAS MRV 3.3 software (Pie Medical Imaging B.V., Netherlands) for calculation of the MPRI. The stress CMRI was performed using a standardized protocol in 20 women including 10 women with angina and the absence of obstructive CAD and 10 healthy volunteers. MPRI calculation was made in a standardized manner on separate occasions by two independent observers. A single observer repeated the calculation of MPRI three months later, without reference to the prior data. Basal, mid, and apical segments, for the whole myocardium, sub-endocardium, and sub-epicardium were analyzed. Intra-class correlation coefficients (ICC), repeatability coefficients (RC), and coefficients of variation (CoV) were determined.
RESULTS: The MPRI results by repeated software measurements were highly correlated, with potentially important variations in measurement observed. The myocardial inter-observer ICC was 0.80 (95% CI, 0.57, 0.92) with a CoV of 7.5%, and intra-observer ICC was 0.89 (95% CI, 0.77, 0.95) with a CoV of 3.6%. The mid-ventricular level MPRI was most reproducible, with intra-observer ICC at 0.91 (95% CI, 0.77, 0.97); intra-observer measurement was more reproducible than inter-observer measurement.
CONCLUSIONS: There is variation in measurement of MPRI observed in post processing of perfusion data when using a standardized approach and commercially available software. This has implications in the interpretation of data obtained for clinical and research purposes.

Entities:  

Keywords:  Cardiac magnetic resonance; myocardial perfusion reserve; reproducibility

Year:  2012        PMID: 24282727      PMCID: PMC3839165          DOI: 10.3978/j.issn.2223-3652.2012.10.02

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  21 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging.

Authors:  Igor Klem; John F Heitner; Dipan J Shah; Michael H Sketch; Victor Behar; Jonathan Weinsaft; Peter Cawley; Michele Parker; Michael Elliott; Robert M Judd; Raymond J Kim
Journal:  J Am Coll Cardiol       Date:  2006-03-27       Impact factor: 24.094

Review 3.  Applying the right statistics: analyses of measurement studies.

Authors:  J M Bland; D G Altman
Journal:  Ultrasound Obstet Gynecol       Date:  2003-07       Impact factor: 7.299

Review 4.  Role of cardiac magnetic resonance imaging in the assessment of myocardial viability.

Authors:  Kesavan Shan; Godwin Constantine; Mohan Sivananthan; Scott D Flamm
Journal:  Circulation       Date:  2004-03-23       Impact factor: 29.690

5.  Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.

Authors:  Janet Wei; Puja K Mehta; B Delia Johnson; Bruce Samuels; Saibal Kar; R David Anderson; Babak Azarbal; John Petersen; Barry Sharaf; Eileen Handberg; Chrisandra Shufelt; Kamlesh Kothawade; George Sopko; Amir Lerman; Leslee Shaw; Sheryl F Kelsey; Carl J Pepine; C Noel Bairey Merz
Journal:  JACC Cardiovasc Interv       Date:  2012-06       Impact factor: 11.195

6.  Perfusion abnormality, normal coronaries, and chest pain.

Authors:  Dudley J Pennell
Journal:  J Am Coll Cardiol       Date:  2008-01-29       Impact factor: 24.094

7.  Ischemic heart disease in women.

Authors:  Carl J Pepine
Journal:  J Am Coll Cardiol       Date:  2006-02-07       Impact factor: 24.094

8.  Comparison of clinical tools for measurements of regional stress and rest myocardial blood flow assessed with 13N-ammonia PET/CT.

Authors:  Piotr J Slomka; Erick Alexanderson; Rodrigo Jácome; Moises Jiménez; Edgar Romero; Aloha Meave; Ludovic Le Meunier; Magnus Dalhbom; Daniel S Berman; Guido Germano; Heinrich Schelbert
Journal:  J Nucl Med       Date:  2012-01-06       Impact factor: 10.057

9.  Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging.

Authors:  Jonathan R Panting; Peter D Gatehouse; Guang-Zhong Yang; Frank Grothues; David N Firmin; Peter Collins; Dudley J Pennell
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

10.  Reproducibility of adenosine stress cardiovascular magnetic resonance in multi-vessel symptomatic coronary artery disease.

Authors:  Sharon Chih; Peter S Macdonald; Michael P Feneley; Matthew Law; Robert M Graham; Jane A McCrohon
Journal:  J Cardiovasc Magn Reson       Date:  2010-07-21       Impact factor: 5.364

View more
  12 in total

1.  Variability in quantitative cardiac magnetic resonance perfusion analysis.

Authors:  K Bratis; Eike Nagel
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

2.  Reproducibility of a cardiac magnetic resonance derived myocardial perfusion reserve index.

Authors:  Geraint Morton
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

3.  Going with the flow: how reproducible are cardiac magnetic resonance measurements of myocardial perfusion?

Authors:  John Biglands; Sven Plein
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

4.  Myocardial perfusion reserve index during adenosine stress magnetic resonance for the detection of coronary artery disease - ready for prime time?

Authors:  Grigorios Korosoglou; Hugo A Katus
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

5.  Improved diagnosis and prognosis using Decisions Informed by Combining Entities (DICE): results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Mark Doyle; Gerald M Pohost; C Noel Bairey Merz; Leslee J Shaw; George Sopko; William J Rogers; Barry L Sharaf; Carl J Pepine; Diane A Vido-Thompson; Geetha Rayarao; Lindsey Tauxe; Sheryl F Kelsey; Douglas Mc Nair; Robert W Biederman
Journal:  Cardiovasc Diagn Ther       Date:  2013-12

6.  Diastolic dysfunction in women with signs and symptoms of ischemia in the absence of obstructive coronary artery disease: a hypothesis-generating study.

Authors:  Michael D Nelson; Lidia S Szczepaniak; Janet Wei; Afsaneh Haftabaradaren; Meghan Bharadwaj; Behzad Sharif; Puja Mehta; Xiao Zhang; Louise E Thomson; Daniel S Berman; Debiao Li; C Noel Bairey Merz
Journal:  Circ Cardiovasc Imaging       Date:  2014-03-14       Impact factor: 7.792

7.  Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE).

Authors:  Mark Doyle; Gerald M Pohost; C Noel Bairey Merz; Leslee J Shaw; George Sopko; William J Rogers; Barry L Sharaf; Carl J Pepine; Diane V Thompson; Geetha Rayarao; Lindsey Tauxe; Sheryl F Kelsey; Robert W W Biederman
Journal:  Cardiovasc Diagn Ther       Date:  2016-10

8.  Cardiac magnetic resonance imaging for myocardial perfusion and diastolic function-reference control values for women.

Authors:  May Bakir; Janet Wei; Michael D Nelson; Puja K Mehta; Afsaneh Haftbaradaran; Erika Jones; Edward Gill; Behzad Sharif; Piotr J Slomka; Debiao Li; Chrisandra L Shufelt; Margo Minissian; Daniel S Berman; C Noel Bairey Merz; Louise E J Thomson
Journal:  Cardiovasc Diagn Ther       Date:  2016-02

9.  Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction ancillary study.

Authors:  Cecil A Rambarat; Islam Y Elgendy; Eileen M Handberg; C Noel Bairey Merz; Janet Wei; Margo B Minissian; Michael D Nelson; Louise E J Thomson; Daniel S Berman; Leslee J Shaw; Galen Cook-Wiens; Carl J Pepine
Journal:  Int J Cardiol       Date:  2018-09-26       Impact factor: 4.039

10.  A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve.

Authors:  C Noel Bairey Merz; Eileen M Handberg; Chrisandra L Shufelt; Puja K Mehta; Margo B Minissian; Janet Wei; Louise E J Thomson; Daniel S Berman; Leslee J Shaw; John W Petersen; Garrett H Brown; R David Anderson; Jonathan J Shuster; Galen Cook-Wiens; André Rogatko; Carl J Pepine
Journal:  Eur Heart J       Date:  2015-11-27       Impact factor: 35.855

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.